SARS-CoV-2 infection in patients with multiple myeloma: survey in 23 centers across Europe and USA

Dytfeld D., Radocha J., Hajek R., CENGİZ SEVAL G., Berkac M., Coriu D., ...Daha Fazla

Acta Haematologica Polonica, cilt.54, sa.2, ss.82-85, 2023 (Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 54 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.5603/ahp.a2023.0016
  • Dergi Adı: Acta Haematologica Polonica
  • Derginin Tarandığı İndeksler: Scopus, BIOSIS, Central & Eastern European Academic Source (CEEAS), EMBASE
  • Sayfa Sayıları: ss.82-85
  • Anahtar Kelimeler: COVID-19, myeloma
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: Despite several studies, the impact of coronavirus disease 2019 on patients with multiple myeloma remains uncertain. Material and methods: We performed a survey that covered the period of the first and second waves of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic in 23 centers inseven countries. Out of 352 patients with myeloma and SARS-CoV-2, 23% died. Results/Conclusions: Logistic regression showed a lower risk of death among patients treated with proteasome inhibitor and a higher risk of death for those who had a severe or a very severe course of disease.